"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Goldman Sachs says there's still life left in value investing, especially with the Federal Reserve set to cut rates again.Marketsread more
Shopify debuts a new network to help it compete with Amazon.Marketsread more
Nineteen billionaires release a letter asking the 2020 presidential candidates to support a tax on America's richest families.Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
Apple released the iOS 13 public beta and the iPadOS public preview, which means you can check out the new features before the update launches in the fall.Technologyread more
Home Depot CEO Craig Menear said the company aims to minimize any impact that potential tariffs will have on customers by cutting costs elsewhere in the supply chain. The...Retailread more
Shares of Bristol-Myers Squibb plunged Monday after announcing that the target closing date for the proposed acquisition of Celgene has been pushed back and that the deal will...Biotech and Pharmaceuticalsread more
These are the stocks posting the largest moves midday.Market Insiderread more
She takes the helm after Kevin Tsujihara exited the company in March amid an inappropriate relationship with an actress.Entertainmentread more
The Trump administration had argued the president has wide-ranging authority over national security matters.Politicsread more
Amid the recent volatility in pot stocks, there is one group that appears to be capitalizing on the cannabis industry: the banks advising on a flourishing deal market for these companies.
About $582 million has been raised for cannabis companies through initial public offerings to date, while nearly $8 billion in mergers and acquisitions have been inked, according to data provided by Dealogic. An even greater number of deals have been done through less-traditional methods, such as reverse mergers and private placements.
That has been a boon to Canadian banks, in particular. Firms from Canada don't typically appear at the top of the so-called league tables — the quarterly and annual rankings of investment banks based on the amount of fees they generate from deals — as those spots are typically taken by large U.S. banks like Goldman Sachs and J.P. Morgan.
But when it comes to the cannabis industry, Canadian banks like Canaccord Genuity and BMO Capital Markets hold the highest rank, according to Dealogic.
Part of that has to do with the size of the deals — they're still relatively small and don't always capture the attention of the larger American banks. But even the bigger deals tend to be managed by Canadian firms, thanks to the lack of regulatory risk those firms face.
While it's not illegal for U.S. firms to participate in these deals, the fact that pot is legal on a federal level in Canada makes it easier for Canadian banks to participate, according to Harrison Phillips, vice president at Viridian Capital Advisors.
"The rules as they stand play in the favor of Canadian operators and institutions, investment banks included," said Phillips of Viridian, a financial advisory firm that focuses on the cannabis market. "So rather than operators and investors trying to price the risk of federal illegality, they've moved to the capital markets that are more favorable to the space."
A list of M&A advisers in the cannabis sector provided by Dealogic shows that the top eight firms are all Canada-based. The ninth is Greenhill, an American investment bank. On the IPO side, there are a few more American investment banks, including Cowen, which is tied with BMO Capital Markets for first place,thanks solely to its work for medical marijuana producer, Tilray, which went public in July.
As financial institutions become more comfortable with the rules and regulations on a federal level, they'll be more inclined to work with cannabis providers. The number of regional banks and credit unions serving the industry has grown almost 30 percent, to 411, between October 2016 and March of 2018, according to Frontier Financial Group.
Of course, one thing that could change the game for American investment banks is legalization on a federal level. A recent report by Canaccord Genuity said the looming midterm elections could be a catalyst.
"Conventional thinking holds that a Democratic-controlled House would be positive for federal legalization efforts," Canaccord analysts wrote in the report.
But in the meantime, and despite the potential market opportunity that cannabis may have in the U.S., large investment banks are likely to remain on the sidelines.
"Investment banks want to make sure they're not aiding and abetting and violating U.S. law," said Phillips of Viridian. "I believe it just comes down to risk versus reward."